A class action lawsuit alleging excessive oil consumption from the GM Vortec 5.3L 5300 V8 engine has officially been settled, ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...

General Motors introduced the 5.3-liter Vortec V8 back in 1999 and kept it in production for 15 years. Over that time, it became one of the most popular small-block engines in GM's lineup, offering ...

The 5.3-liter V8 Ecotec3 might seem like the stepchild of the General Motors family, especially with the LS series of engines around, but it's a winner in its own right. This naturally aspirated ...

With the launch of Chevy's small-block V8 in 1955, General Motors introduced an engine family that would make its way into millions of vehicles across the world. It was especially known as a mainstay ...

Bruno started at Top Speed in 2022 and now serves as Senior Editor for ICE while also training writers across CarBuzz, HotCars, and TopSpeed. A car and motorcycle enthusiast, he enjoys writing about ...

The first-generation 3.0-liter LM2 Duramax diesel engine was a GM product manufactured in Michigan. The engine became the first diesel for GM's Chevy and GMC light-duty trucks since 1997, and the ...

Chevy’s 5.3-liter V8 was dropped in 2022 from the Silverado engine lineup. It has direct ties to its infamous small block engine that first appeared in 1955. Over the years it has seen continual ...

While the 5.3L LS4 V8 was the first car engine to feature Active Fuel Management (cylinder deactivation) technology, it was not Flex Fuel capable and did not have variable valve timing. As mentioned, ...

The Aveo comes with ABS and front and side airbags as standard, plus remote central locking and an immobiliser for security. Keep it in the city, and the Aveo is an easy car to live with. It’s compact ...

Biologics sales grew at an incredible rate during the past 18 months, especially when compared with pharmaceuticals. But with pressure on pricing and biosimilars looming, how long will it be until ...